Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 37.69%341.65M | 27.08%307.9M | 28.77%299.99M | 31.34%1.02B | 32.19%293.53M | 27.82%248.13M | 31.05%242.28M | 34.48%232.96M | 18.91%774.26M | 34.63%222.04M |
| Cost of revenue | 2.30%119.63M | -23.73%116.94M | ||||||||
| Gross profit | 36.50%897.27M | 32.05%657.32M | ||||||||
| Operating expense | 88.76%111.39M | 43.96%86.89M | 37.17%85.5M | -12.81%111.95M | 40.54%83.93M | -0.17%59.01M | -4.37%60.36M | -9.26%62.33M | 51.53%128.39M | 145.66%59.72M |
| Selling and administrative expenses | ---- | ---- | ---- | 29.14%96.34M | ---- | ---- | ---- | ---- | 3.39%74.6M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 29.14%96.34M | ---- | ---- | ---- | ---- | 3.39%74.6M | ---- |
| Depreciation and amortization | 22.81%15.9M | 2.08%13.85M | -18.54%11.5M | -7.23%54.82M | -5.52%14.18M | -10.90%12.95M | -8.65%13.57M | -3.89%14.12M | --59.09M | --15.01M |
| -Depreciation | 22.81%15.9M | 2.08%13.85M | -18.54%11.5M | -7.23%54.82M | -5.52%14.18M | -10.90%12.95M | -8.65%13.57M | -3.89%14.12M | --59.09M | --15.01M |
| Other operating expenses | 107.30%95.49M | 56.11%73.04M | 53.49%74M | -6.44%55.01M | 55.99%69.75M | 3.33%46.06M | -3.05%46.79M | -10.72%48.21M | -5.16%58.79M | 141.28%44.72M |
| Total other operating income | ---- | ---- | ---- | 687.35%39.4M | ---- | ---- | ---- | ---- | -89.87%5M | ---- |
| Operating profit | 21.75%230.25M | 21.48%221.01M | 25.70%214.49M | 48.47%785.32M | 29.12%209.59M | 40.08%189.12M | 49.41%181.93M | 63.22%170.63M | 28.06%528.93M | 13.98%162.32M |
| Net non-operating interest income (expenses) | -52.65%-24.67M | -6.28%-17.47M | -24.81%-17.51M | -67.11%-66.78M | -66.34%-18.79M | -7.75%-16.16M | -79.33%-16.43M | -297.76%-14.03M | -332.41%-39.96M | -281.24%-11.3M |
| Non-operating interest income | -23.65%113K | -72.42%179K | -77.81%81K | 38.89%1.35M | -50.91%188K | -58.07%148K | 930.16%649K | 110.98%365K | --972K | --383K |
| Non-operating interest expense | 51.96%24.79M | 3.29%17.65M | 22.20%17.6M | 67.11%66.78M | 62.50%18.98M | 6.24%16.31M | 85.14%17.08M | 289.03%14.4M | 332.41%39.96M | 333.36%11.68M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -39.26%15.08M | -5.06M | -15.76M | 315.72%15.6M | -1,180.80%-9.23M | 17,265.03%24.83M | 0 | 0 | 3.75M | 854K |
| Income from associates and other participating interests | 31.76%307K | -38.45%293K | 252.50%423K | 58.53%688K | -1,275.00%-141K | 32.39%233K | 268.99%476K | 2.56%120K | 250.00%434K | -79.31%12K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 11,900.00%120K | 400.00%27K | -168.42%-39K | -85.15%86K | 123.72%37K | -99.53%1K | -137.50%-9K | -88.53%57K | 579K | -156K |
| Income before tax | 11.65%221.09M | 19.79%198.8M | 15.84%181.6M | 46.96%719.23M | 19.60%181.47M | 64.27%198.02M | 48.51%165.96M | 48.77%156.77M | 21.03%489.41M | 101.79%151.73M |
| Income tax | -67.37%924K | -24.48%469K | -95.05%28K | 335.85%11.18M | -82.48%295K | 539.28%2.83M | 55.25%621K | 1,351.28%566K | -35.28%2.57M | 360.11%1.68M |
| Net income | 12.80%220.17M | 19.95%198.33M | 16.24%181.57M | 45.44%708.05M | 20.74%181.17M | 62.52%195.19M | 48.48%165.34M | 48.29%156.21M | 21.59%486.84M | 100.53%150.05M |
| Net income continuous operations | 12.80%220.17M | 19.95%198.33M | 16.24%181.57M | 45.44%708.05M | 20.74%181.17M | 62.52%195.19M | 48.48%165.34M | 48.29%156.21M | 21.59%486.84M | 100.53%150.05M |
| Noncontrolling interests | -240.00%-196K | -885.54%-818K | -127.84%-71K | 144.50%360K | 142.86%48K | 33.33%140K | 59.51%-83K | 142.71%255K | -146.49%-809K | -182.96%-112K |
| Net income attributable to the company | 12.98%220.36M | 20.39%199.15M | 16.47%181.64M | 45.12%707.69M | 20.62%181.13M | 62.55%195.05M | 48.29%165.42M | 47.21%155.95M | 22.32%487.65M | 101.04%150.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.98%220.36M | 20.39%199.15M | 16.47%181.64M | 45.12%707.69M | 20.62%181.13M | 62.55%195.05M | 48.29%165.42M | 47.21%155.95M | 22.32%487.65M | 101.04%150.16M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 11.54%0.029 | 18.18%0.026 | 14.29%0.024 | 43.99%0.0946 | 20.00%0.024 | 62.50%0.026 | 46.67%0.022 | 50.00%0.021 | 21.89%0.0657 | 102.02%0.02 |
| Diluted earnings per share | 11.54%0.029 | 18.18%0.026 | 14.29%0.024 | 43.99%0.0946 | 20.00%0.024 | 62.50%0.026 | 46.67%0.022 | 50.00%0.021 | 21.89%0.0657 | 102.02%0.02 |
| Dividend per share | 48.21%0.0249 | 0 | 0 | 35.92%0.0193 | 0.00%0.0025 | 43.59%0.0168 | 0 | 0 | 10.94%0.0142 | 0.00%0.0025 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.